Latest Treatments for Acute Lymphocytic Leukemia


Related Videos (117)

This 2016 update on Acute Lymphocytic Leukemia (ALL) from Noelle Frey, MD, features a review of treatment approaches for ALL patients in the unique adolescent/young adult population, among other findings. Reviewing clinical trials that suggest a correlation between improved outcomes in this population when exposed to an intensity of treatment typical of pediatric ALL patients, Dr Frey notes the rapid decline in tolerability beyond age 20. For adult patients in relapse, Dr. Frey reports on studies that found durable remission and cure dependent on the capacity to bridge patients to an allogeneic transplant, and speaks to the value of detecting minimal residual disease as a correlate to prognosis throughout the course of disease.


Penn PhysicianLink®

Penn PhysicianLink® is an exclusive program that helps all referring physicians connect with Penn Medicine. This comprehensive package of support services expedites and facilitates direct physician communication for patient consults, referrals and transfers.

Learn more about Penn PhysicianLink®